BBIO·10806X102·US·equity·Healthcare - Biotechnology-Activist
BBIO (BRIDGEBIO PHARMA INC) is held by 195 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), JANUS HENDERSON GROUP PLC ($978.6M), VIKING GLOBAL INVESTORS LP ($879.4M). Net institutional sentiment: Mixed.
See how BBIO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer